ARCHITECT LH MASTERCHECK, MODEL NUMBER 6C25-05

K984323 · Bio-Rad · JJX · Dec 15, 1998 · Clinical Chemistry

Device Facts

• Record ID: K984323
• Device Name: ARCHITECT LH MASTERCHECK, MODEL NUMBER 6C25-05
• Applicant: Bio-Rad
• Product Code: JJX · Clinical Chemistry
• Decision Date: Dec 15, 1998
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 862.1660
• Device Class: Class 1

Intended Use

Architect LH MasterCheck is intended for use in the verification of sensitivity, calibration linearity, and reportable range of the LH assay on the Abbott Architect i System.

Device Story

Architect LH MasterCheck is a liquid, multi-level control product used in clinical laboratory settings to verify the performance of the LH assay on the Abbott Architect i System. The device consists of four levels: Level 0 (HEPES buffer with bovine protein stabilizers) and Levels 1, 2, and 3 (human LH in HEPES buffer with bovine protein stabilizers and antimicrobial agents). Laboratory technicians use the product to assess calibration linearity, sensitivity, and reportable range of the assay. By comparing the measured values of the MasterCheck against expected ranges, the healthcare provider confirms the accuracy and reliability of the analyzer's output, ensuring the validity of patient test results.

Clinical Evidence

No clinical data. Bench testing only.

Technological Characteristics

Liquid control material. Composition: HEPES buffer, bovine protein stabilizers, human LH (Levels 1-3), antimicrobial agent. Storage: 2-8°C. Open vial stability: 3 days at 2-8°C. Intended for use with Abbott Architect i System.

Indications for Use

Indicated for use as a calibration verification material for the LH assay on the Abbott Architect i System to verify sensitivity, calibration linearity, and reportable range.

Regulatory Classification

Identification

A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.

Predicate Devices

• Serum Multi-Analyte Verification Test Set Casco Standards Yarmouth, ME (K950469)

Submission Summary (Full Text)

{0}------------------------------------------------

DEC 15 1998

Image /page/0/Picture/1 description: The image shows the logo for BIO-RAD. The logo is white text on a black background. The text is in all capital letters and is bolded.

Bio-Rad Laboratories

Diagnostics Group 0 Jeronimo Road Irvine, California 92618-2017 lephone: [phone]

984323

## 510(k) Summary

Submitter Bio-Rad Laboratories 9500 Jeronimo Road Irvine, CA [phone] Fax [phone]

Contact Person Elizabeth Platt

Date of Summary Preparation December 02, 1998

Device (Trade & Common Name) Architect LH MasterCheck

Classification Name Class 1, 75JJX CFR 862.1660: Single (Specified) Analyte Controls (Assayed and Unassayed)

Devices to Which Substantial Equivalence is Claimed Document Serum Multi-Analyte Verification Test Set Casco Standards Yarmouth, ME K950469

## Statement of Intended Use

Architect LH MasterCheck is intended for use in the verification of sensitivity, calibration linearity, and reportable range of the LH assay on the Abbott Architect i System.

{1}------------------------------------------------

Image /page/1/Picture/0 description: The image shows the logo for BIO-RAD. The logo is white text on a black background. The text is in a bold, sans-serif font. The logo is enclosed in a rounded rectangle.

Bio-Rad Laboratories Diagnostics Group 9500 Jeronimo Road Irvine, California 92618-2017 Telephone: [phone]

Description of the Device

Architect LH MasterCheck Level 0 contains HEPES buffer with protein (bovine) stabilizers.

Architect LH MasterCheck Levels 1, 2, and 3 contain LH (human) prepared in HEPES buffer with protein (bovine) stabilizers.

Preservative: Antimicrobial Agent.

Statement of How Technological Characteristics Compare to Substantial Equivalence Device

A table is provided below comparing the similarities between the Bio-Rad Architect LH MasterCheck and the devices to which substantial equivalence is claimed.

| | Architect LH MasterCheck | Casco Standards Document<br>Serum Multi-Analyte<br>Verification Test Set |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended<br>Use | Verification of sensitivity,<br>calibration linearity, and<br>reportable range of the LH<br>assay on the Abbott Architect i<br>System. | In vitro diagnostic use in the<br>quantitative determination of<br>linearity, calibration<br>verification and verification<br>of reportable range using<br>automated, semi-automated<br>and manual methods. |
| Form | Liquid | Liquid |
| Matrix | HEPES buffer with protein<br>(bovine) stabilizers | Human Serum |
| Storage | 2-8°C | -10 to -20°C |
| Analytes | LH | Multiple |
| Open Vial<br>Claim | 3 Days at 2-8°C. | 30 Days at 2-8°C. |
| Differences | Calibration verifier for the<br>Architect LH assay | Calibration verifier for<br>multiple analytes. |

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. In the center of the seal is a stylized image of an eagle with its wings spread, with three lines representing the wings and body. The eagle is facing to the right.

## DEC 15 1998

Ms. Elizabeth Platt Regulatory Affairs Supervisor Bio-Rad Laboratories Diagnostics Group 9500 Jeronimo Road Irvine, California 92618-2017

Re : K984323 Architect LH MasterCheck Trade Name: Requlatory Class: I Product Code: JJX Dated: December 2, 1998 Received: December 3, 1998

Dear Ms. Platt:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obliqation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

{3}------------------------------------------------

Paqe 2

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone], or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Steven Sutman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Page 1 of 1

1984323 510(k) Number: Device Name: Architect LH MasterCheck

Indications for Use:

Architect LH MasterCheck is intended for use in the verification of sensitivity, calibration linearity, and reportable range of the LH assay on the Abbott Architect i System.

(Division Sign-Off)
Division of Clinical Laboratory Devices
510(k) Number. K984323

(PLEASE DO NOT WRITE BELOW THE LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

(Concurrence of CDRH, Office of Device Evaluation)

Prescription Use __

Over-The Counter Use OR